Chagas disease in the state of Jalisco, Mexico was described for the first time in 1967; however, knowledge on the disease remains in a slow process. Between 1967 and 2006, the disease was described in its acute and chronic forms. The vector species have been identified, and the parasite Trypanosoma cruzi has been isolated and genetically characterized. Also, the magnitude of the infection in humans has been determined through serological studies of different populations as well as of blood donors. The up-to-dateness of knowledge of the disease in the state of Jalisco, unveils a necessity of increased research on the epidemiology of Chagas disease as well as on clinical studies to assess the health of individuals and the populations.
El objetivo de este escrito, es presentar los datos clínicos, quirúrgicos, paraclínicos, terapeúticos, y epidemiológicos que sustentan la existencia del primer caso de trasplante cardíaco por cardiopatía chagásica en México. Se trata de un paciente masculino de 35 años de edad, al que se realizó trasplante cardiaco por cardiomiopatia dilatada no compatible con la vida; comprobado por serología y aislamiento del T. cruzi posterior a la intervención quirúrgica realizada al presentar complicaciones posteriores al trasplante. A 9 años del trasplante, el paciente se considera curado y reintegrado al trabajo. Los pacientes diagnosticados clínicamente con miocardiopatía dilatada y serología positiva a T cruzi, son frecuentes, en el orden de 15% en el país. La presencia del presente caso y la circunstancia en que se diagnosticó, orienta la existencia de un mayor número de casos ya trasplantados y no diagnosticados en el país. Por lo tanto, es necesario reconocer en pacientes candidatos a trasplante cardiaco por miocardiopatía dilatada, la enfermedad de Chagas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.